Suzhou Keyin Biomedical Technology
Latest round
- Series A
Last raised
- Aug 2021
Total raised
- Undisclosed
Investors
- 2
About Suzhou Keyin Biomedical Technology
Based in Suzhou, China and founded in 2020, Suzhou Keyin Biomedical Technology is a medical company dedicated to the research and development of new drugs enabled by AI technology. The founding team of the company has years of experience in chemical biology, biophysics, computational chemistry and artificial intelligence. At present, the company has built the De novo drug design platform, which can explore the whole chemical space and enhance the virtual discovery ability for new targets. The team focuses on early targets in the field of tumor and immunity, and provide patients with the small molecule drugs.
Who invested in Suzhou Keyin Biomedical Technology
2 investors across 1 round
See all investors in Suzhou Keyin Biomedical Technology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 26, 2021
Amount
Undisclosed
Investors
Questions about Suzhou Keyin Biomedical Technology
Who invested in Suzhou Keyin Biomedical Technology?
Suzhou Keyin Biomedical Technology has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Suzhou Keyin Biomedical Technology raised?
Suzhou Keyin Biomedical Technology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Suzhou Keyin Biomedical Technology last raise money?
Suzhou Keyin Biomedical Technology's most recent round on record is a Series A, in Aug 2021.
What does Suzhou Keyin Biomedical Technology do?
Based in Suzhou, China and founded in 2020, Suzhou Keyin Biomedical Technology is a medical company dedicated to the research and development of new drugs enabled by AI technology.
Where is Suzhou Keyin Biomedical Technology headquartered?
Suzhou Keyin Biomedical Technology is headquartered in Suzhou, China.
Which VCs invest in companies like Suzhou Keyin Biomedical Technology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Suzhou Keyin Biomedical Technology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Suzhou Keyin Biomedical Technology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.